Authors:
WORDLICZEK J
BANACH M
FABUZ D
TURCHAN J
SZCZEPANIK AM
PRZEWOCKA B
Citation: J. Wordliczek et al., PENTOXYFILINE BY INHIBITION OF TNF-A RELEASE DECREASES PAIN SENSITIVITY IN RATS, European cytokine network, 9(3), 1998, pp. 20-20
Authors:
RINGHEIM GE
SZCZEPANIK AM
PETKO W
BURGHER KL
ZHU SZ
CHAO CC
Citation: Ge. Ringheim et al., ENHANCEMENT OF BETA-AMYLOID PRECURSOR PROTEIN TRANSCRIPTION AND EXPRESSION BY THE SOLUBLE INTERLEUKIN-6 RECEPTOR INTERLEUKIN-6 COMPLEX, Molecular brain research, 55(1), 1998, pp. 35-44
Authors:
RINGHEIM GE
PETKO W
BURGHER K
SZCZEPANIK AM
Citation: Ge. Ringheim et al., ENHANCEMENT OF BETA-AMYLOID PRECURSOR PROTEIN TRANSCRIPTION BY THE SOLUBLE INTERLEUKIN-6 RECEPTOR INTERLEUKIN-6 COMPLEX, The FASEB journal, 11(3), 1997, pp. 1852-1852
Citation: Am. Szczepanik et Ca. Wilmot, EFFECTS OF RITANSERIN ON HALOPERIDOL-INDUCED DOPAMINE (D-2) RECEPTOR UP-REGULATION IN THE RAT, Neuroscience letters, 231(2), 1997, pp. 91-94
Authors:
PAN JM
BURGHER KL
SZCZEPANIK AM
RINGHEIM GE
Citation: Jm. Pan et al., TYROSINE PHOSPHORYLATION OF INDUCIBLE NITRIC-OXIDE SYNTHASE - IMPLICATIONS FOR POTENTIAL POSTTRANSLATIONAL REGULATION, Biochemical journal, 314, 1996, pp. 889-894
Authors:
SZCZEPANIK AM
BROUGHAM LR
ROEHR JE
CONWAY PG
ELLIS DB
WILMOT CA
Citation: Am. Szczepanik et al., EX-VIVO STUDIES WITH ILOPERIDONE (HP-873), A POTENTIAL ATYPICAL ANTIPSYCHOTIC WITH DOPAMINE D-2 5-HYDROXYTRYPTAMINE(2) RECEPTOR ANTAGONIST ACTIVITY/, The Journal of pharmacology and experimental therapeutics, 278(2), 1996, pp. 913-920
Citation: Ja. Heroux et Am. Szczepanik, QUANTITATIVE-ANALYSIS OF SPECIFIC MESSENGER-RNA TRANSCRIPTS USING A COMPETITIVE PCR ASSAY WITH ELECTROCHEMILUMINESCENT DETECTION, PCR methods and applications, 4(6), 1995, pp. 327-330
Authors:
KARCZ D
POPIELA T
SZCZEPANIK AM
CZUPRYNA A
SZYMANSKA B
SIEDLAR M
ZEMBALA M
Citation: D. Karcz et al., PREOPERATIVE ENDOSCOPIC INTRATUMOR APPLICATION OF TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH LOCALLY ADVANCED RESECTABLE GASTRIC-CANCER, Endoscopy, 26(4), 1994, pp. 369-370